DOI:
10.1055/s-00023610
Drug Research
LinksClose Window
References
Halvorsen YD, Lock JP, Zhou W. et al
A 24–week, randomized, double-blind, active-controlled clinical trial
comparing bexagliflozin with sitagliptin as an adjunct to metformin for the
treatment of type 2 diabetes in adults.
Diabetes, Obesity and Metabolism 2019;
21: 2248-2256
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.